{"transactions":[{"id":693148,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-08-07T20:32:04.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":33557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units (\"PSUs\") originally granted to the reporting person on February 28, 2024 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, subject generally to the reporting person's continued employment through such date."}],"balance_after":264241,"source":{"system":"sec-edgar","filing":"0001860742-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000090/form4.xml","form_type":"4"}},{"id":800104,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-04-27T20:42:20.000Z","date":"2026-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":15806,"price":15.82,"value":250050.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units."}],"balance_after":230684,"source":{"system":"sec-edgar","filing":"0001860742-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000057/form4.xml","form_type":"4"}},{"id":851187,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-03-10T21:23:22.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents matching restricted share units (\"MRSUs\") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances)."}],"balance_after":246490,"source":{"system":"sec-edgar","filing":"0001860742-26-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000056/form4.xml","form_type":"4"}},{"id":851186,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-03-10T21:23:22.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":14600,"price":17.146,"value":250331.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are held by the reporting person's self-directed IRAs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.101 to $17.20 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":231890,"source":{"system":"sec-edgar","filing":"0001860742-26-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000056/form4.xml","form_type":"4"}},{"id":874463,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-03-02T22:46:43.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":2461,"price":18.3,"value":45036.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units."}],"balance_after":217290,"source":{"system":"sec-edgar","filing":"0001860742-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000043/form4.xml","form_type":"4"}},{"id":874462,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-03-02T22:46:43.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3395,"price":18.49,"value":62773.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units."}],"balance_after":219751,"source":{"system":"sec-edgar","filing":"0001860742-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000043/form4.xml","form_type":"4"}},{"id":877462,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2026-02-27T21:13:51.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":52570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted share units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the \"Plan\") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation."}],"balance_after":223146,"source":{"system":"sec-edgar","filing":"0001860742-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000033/form4.xml","form_type":"4"}},{"id":1165757,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2025-04-25T20:05:50.000Z","date":"2025-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":9781,"price":13.89,"value":135858.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units."}],"balance_after":170576,"source":{"system":"sec-edgar","filing":"0001127602-25-012621","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760225012621/form4.xml","form_type":"4"}},{"id":1238709,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2025-02-28T21:27:22.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":96566,"price":15.86,"value":1531536.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the grant of stock options to purchase common shares under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The stock options will expire on the tenth anniversary of the grant date."}],"balance_after":96566,"derivative":{"exercise_price":15.86,"underlying":"Common Shares, No Par Value","underlying_shares":96566},"source":{"system":"sec-edgar","filing":"0001127602-25-007270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760225007270/form4.xml","form_type":"4"}},{"id":1238708,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2025-02-28T21:27:22.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":40540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the \"Plan\") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation."}],"balance_after":180357,"source":{"system":"sec-edgar","filing":"0001127602-25-007270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760225007270/form4.xml","form_type":"4"}},{"id":1321810,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2024-12-26T21:12:02.000Z","date":"2024-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":4402,"price":17.83,"value":78487.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units."}],"balance_after":139817,"source":{"system":"sec-edgar","filing":"0001127602-24-030050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224030050/form4.xml","form_type":"4"}},{"id":1534854,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2024-04-26T20:08:41.000Z","date":"2024-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":9838,"price":14.9,"value":146586.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units."}],"balance_after":144219,"source":{"system":"sec-edgar","filing":"0001127602-24-013447","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224013447/form4.xml","form_type":"4"}},{"id":1607506,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2024-03-01T21:22:10.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":101626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the grant of stock options to purchase common shares under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The stock options will expire on the tenth anniversary of the grant date."}],"balance_after":101626,"derivative":{"exercise_price":16.85,"underlying":"Common Shares, No Par Value","underlying_shares":101626},"source":{"system":"sec-edgar","filing":"0001127602-24-007872","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224007872/form4.xml","form_type":"4"}},{"id":1607505,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2024-03-01T21:22:10.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":33557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the \"Plan\") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation."}],"balance_after":154057,"source":{"system":"sec-edgar","filing":"0001127602-24-007872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224007872/form4.xml","form_type":"4"}},{"id":1903034,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2023-05-05T21:34:41.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":429184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects an award of stock options to purchase common shares granted to the reporting person under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan on May 4, 2023. Each stock option reflects the right to purchase one common share, subject to the terms of the Plan and the applicable award agreement. The stock options are scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date."}],"balance_after":429184,"derivative":{"exercise_price":17.5,"expiration_date":"2033-05-04","underlying":"Common Shares, No Par Value","underlying_shares":429184},"source":{"system":"sec-edgar","filing":"0001127602-23-014768","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223014768/form4.xml","form_type":"4"}},{"id":1913424,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"officer":true,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Shares, No Par Value","published_at":"2023-04-26T21:20:34.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":120500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation."}],"balance_after":120500,"source":{"system":"sec-edgar","filing":"0001127602-23-013581","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223013581/form4.xml","form_type":"4"}},{"id":3153961,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Performance Stock Units","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":17670,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects the disposition of performance stock units relating to Allergan Shares (\"Allergan PSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, was substituted by AbbVie with an AbbVie restricted stock unit award relating to shares of AbbVie common stock, that vests based on the holder's continued service following the effective time of the Scheme, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formulas set forth in the Transaction Agreement (which, for any Allergan performance stock unit awards that were subject to performance-based vesting conditions on June 25, 2019, was calculated based on deemed satisfaction of performance at 130% of target)."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17670},"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153960,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Stock Options","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":12304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the stock options to purchase Allergan Shares (\"Allergan Options\") were vested as of May 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."}],"balance_after":0,"derivative":{"exercise_price":196.16,"expiration_date":"2020-08-06","underlying":"Ordinary Shares","underlying_shares":12304},"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153959,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Stock Options","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":9750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the stock options to purchase Allergan Shares (\"Allergan Options\") were vested as of May 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."}],"balance_after":0,"derivative":{"exercise_price":103.79,"expiration_date":"2020-08-06","underlying":"Ordinary Shares","underlying_shares":9750},"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153958,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Stock Options","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the stock options to purchase Allergan Shares (\"Allergan Options\") were vested as of May 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."}],"balance_after":0,"derivative":{"exercise_price":196.16,"expiration_date":"2020-08-06","underlying":"Ordinary Shares","underlying_shares":509},"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153957,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Stock Options","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":3852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the stock options to purchase Allergan Shares (\"Allergan Options\") were vested as of May 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."}],"balance_after":0,"derivative":{"exercise_price":103.79,"expiration_date":"2020-08-06","underlying":"Ordinary Shares","underlying_shares":3852},"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153956,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Stock Options","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":16524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the stock options to purchase Allergan Shares (\"Allergan Options\") were vested as of May 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects the disposition of Allergan Options as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Option was substituted by AbbVie with a corresponding AbbVie stock option relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such stock option and the exercise price per share applicable to such stock option determined in accordance with the formulas set forth in the Transaction Agreement."}],"balance_after":0,"derivative":{"exercise_price":224,"expiration_date":"2023-05-08","underlying":"Ordinary Shares","underlying_shares":16524},"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153955,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Units","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the disposition of restricted stock units relating to Allergan Shares (\"Allergan RSUs\") as contemplated by the Transaction Agreement.  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan RSU was substituted by AbbVie with a corresponding AbbVie restricted stock unit award relating to shares of AbbVie common stock, with the number of shares of AbbVie common stock subject to such award determined in accordance with the formula set forth in the Transaction Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3153954,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-05-11T21:48:28.000Z","date":"2020-05-08","kind":"disposition_to_issuer","acquired":false,"shares":17629.307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the disposition of ordinary shares (\"Allergan Shares\") of Allergan plc (\"Allergan\") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. (\"AbbVie\"), Venice Subsidiary, LLC (\"Acquirer Sub\") and Allergan (the \"Transaction Agreement\"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the \"Scheme\").  In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-012754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/doc4.xml","form_type":"4"}},{"id":3180239,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-04-07T18:28:47.000Z","date":"2020-04-03","kind":"tax_withholding","acquired":false,"shares":581,"price":175.71,"value":102087.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the Amended and Restated 2013 Incentive Award Plan of Allergan plc."}],"balance_after":34427.307,"source":{"system":"sec-edgar","filing":"0001179110-20-004761","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911020004761/edgar.xml","form_type":"4"}},{"id":3226439,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-03-04T14:17:59.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":14444,"price":193.84,"value":2799824.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the Amended and Restated 2013 Incentive Award Plan of Allergan plc."}],"balance_after":35008.307,"source":{"system":"sec-edgar","filing":"0001179110-20-003040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911020003040/edgar.xml","form_type":"4"}},{"id":3326621,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2020-01-02T17:51:14.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":1313,"price":191.17,"value":251006.21,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":20564.307,"source":{"system":"sec-edgar","filing":"0001179110-20-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911020000041/edgar.xml","form_type":"4"}},{"id":3561069,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-04-05T15:14:04.000Z","date":"2019-04-03","kind":"tax_withholding","acquired":false,"shares":581,"price":145.71,"value":84657.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":21877.307,"source":{"system":"sec-edgar","filing":"0001179110-19-004796","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911019004796/edgar.xml","form_type":"4"}},{"id":3707427,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-01-03T15:48:45.000Z","date":"2018-12-31","kind":"tax_withholding","acquired":false,"shares":1464,"price":133.66,"value":195678.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":22458.307,"source":{"system":"sec-edgar","filing":"0001179110-19-000194","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911019000194/edgar.xml","form_type":"4"}},{"id":3968215,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-04-05T18:59:48.000Z","date":"2018-04-03","kind":"tax_withholding","acquired":false,"shares":581,"price":164.74,"value":95713.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":23922.307,"source":{"system":"sec-edgar","filing":"0000903423-18-000202","document":"baileyf4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000090342318000202/baileyf4.xml","form_type":"4"}},{"id":4116797,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-01-02T16:39:51.000Z","date":"2017-12-29","kind":"tax_withholding","acquired":false,"shares":1136,"price":163.58,"value":185826.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":24503.307,"source":{"system":"sec-edgar","filing":"0001179110-18-000113","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911018000113/edgar.xml","form_type":"4"}},{"id":4178317,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Performance Based Restricted Share Unit","published_at":"2017-10-30T21:41:05.000Z","date":"2017-10-26","kind":"exercise","acquired":false,"shares":7988,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7988},"source":{"system":"sec-edgar","filing":"0001179110-17-013557","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911017013557/edgar.xml","form_type":"4"}},{"id":4178316,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-10-30T21:41:05.000Z","date":"2017-10-26","kind":"exercise","acquired":true,"shares":7988,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest in equal installments on each of December 31, 2017, December 31, 2018 and December 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":25639.307,"source":{"system":"sec-edgar","filing":"0001179110-17-013557","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911017013557/edgar.xml","form_type":"4"}},{"id":4178315,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.001","published_at":"2017-10-30T21:41:05.000Z","date":"2017-06-16","kind":"other","acquired":true,"shares":2.185,"price":235.96,"value":515.5726,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares reported on previously-filed Form 4s on April 4, 2017 and May 16, 2017, and includes 2.1850 shares acquired on June 16, 2017 pursuant to a broker-assisted dividend reinvestment plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":17651.307,"source":{"system":"sec-edgar","filing":"0001179110-17-013557","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911017013557/edgar.xml","form_type":"4"}},{"id":4178314,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.001","published_at":"2017-10-30T21:41:05.000Z","date":"2017-03-29","kind":"other","acquired":true,"shares":2.122,"price":242.21,"value":513.96962,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2.1220 shares acquired on March 29, 2017 pursuant to a broker-assisted dividend reinvestment plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":12215.122,"source":{"system":"sec-edgar","filing":"0001179110-17-013557","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911017013557/edgar.xml","form_type":"4"}},{"id":4317751,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-05-16T18:09:21.000Z","date":"2017-05-15","kind":"tax_withholding","acquired":false,"shares":456,"price":228.22,"value":104068.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":17647,"source":{"system":"sec-edgar","filing":"0001179110-17-007336","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911017007336/edgar.xml","form_type":"4"}},{"id":4359878,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-04-04T16:25:21.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":5890,"price":237.68,"value":1399935.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest twenty percent (20%) on April 3, 2018, twenty percent (20%) on April 3, 2019, twenty percent (20%) on April 3, 2020, twenty percent (20%) on April 3, 2021 and twenty percent (20%) on April 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":18103,"source":{"system":"sec-edgar","filing":"0001179110-17-005555","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911017005555/edgar.xml","form_type":"4"}},{"id":4554569,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":25473,"kind":"person","name":"Bailey A Robert D","position":1,"cik":"0001591683","reported_name":"Bailey A Robert D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & Corp Sec"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2016-11-15T17:17:42.000Z","date":"2016-11-12","kind":"tax_withholding","acquired":false,"shares":702,"price":207.57,"value":145714.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":12213,"source":{"system":"sec-edgar","filing":"0001179110-16-031624","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578845/000117911016031624/edgar.xml","form_type":"4"}}]}